Pfizer’s Target Boosted at MKM Partners; Valuation Looks Attractive (PFE)

By
A A A
Share |

Pharmaceuticals maker Pfizer Inc. ( PFE ) on Monday received some bullish commentary from analysts at MKM Partners.

The firm reiterated its "Buy" rating on PFE and lifted its price target from $27 to $29. That new target suggests a 14% upside to the stock's Friday closing price of $25.52.

An MKM analyst commented, "Our price target is based on what we consider to be a fair multiple, parity with the group 2013E multiple of 12.7x applied to 2013E PFE earnings of $2.26. Our target price is based on our 3D valuation framework. Pfizer scores below average on its 2012E-2016E pipeline and has the least patent exposure and a slightly below-average score on company-specific factors."


Pfizer shares posted small losses in premarket trading Monday.

The Bottom Line
We have been recommending shares of Pfizer ( PFE ) since Mar.2, 2012, when the stock was trading at $21.49. The company has a 3.45% dividend yield, based on Friday's closing stock price of $25.52.

Pfizer Inc. ( PFE ) is a "Recommended" dividend stock, holding a Dividend.com DARS™ Rating of 3.5 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks , as well as a detailed explanation of our ratings system here .



The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of The NASDAQ OMX Group, Inc.

Created by Dividend.com


This article appears in: Investing , Stocks

Referenced Stocks: PFE

Dividend.com

Dividend.com

More from Dividend.com:

Related Videos

Don't Pay Up to Play REITs
Don't Pay Up to Play REITs          

Stocks

Referenced

87%

Most Active by Volume

100,376,898
  • $17.62 ▲ 0.51%
83,231,837
  • $25.62 ▲ 1.91%
75,739,329
  • $111.78 ▼ 0.77%
65,297,937
  • $36.37 ▼ 1.76%
59,053,093
  • $47.66 ▲ 0.29%
53,482,350
  • $2.59 ▼ 0.38%
51,504,284
  • $7.34 ▲ 2.37%
51,434,656
  • $8.14 ▲ 6.96%
As of 12/19/2014, 04:15 PM


Find a Credit Card

Select a credit card product by:
Select an offer:
Search
Data Provided by BankRate.com